Welcome to the Podiatry Arena forums

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members, upload content, view attachments, receive a weekly email update of new discussions, access other special features. Registered users do not get displayed the advertisements in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

  1. Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
    Dismiss Notice
Dismiss Notice
Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
Dismiss Notice
Have you liked us on Facebook to get our updates? Please do. Click here for our Facebook page.
Dismiss Notice
Do you get the weekly newsletter that Podiatry Arena sends out to update everybody? If not, click here to organise this.

Nifedipine Vs Placebo For Treatment Of Chilblains

Discussion in 'General Issues and Discussion Forum' started by NewsBot, Sep 17, 2016.

Tags:
  1. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1

    Members do not see these Ads. Sign Up.
    Nifedipine vs Placebo for Treatment of Chronic Chilblains: A Randomized Controlled Trial
    Ibo H. Souwer et al
    Ann Fam MedSeptember/October 2016 vol. 14 no. 5 453-459
     
  2. Admin2

    Admin2 Administrator Staff Member

  3. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Sildenafil is an Effective Therapy for Treatment of Chilblain in Female
    Patients with Bacteriological Study of Ulcerative Lesions

    Prof. Dr. Khudhair Khalaf Al-Kayalli, M.B.Ch.B, F.I.B.M.S Burooj Mohammed Razooqi Al-aajem, M.Sc.
    Mustansiriya Medical Journal Volume 16 Issue 3 December
     
  4. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Development of a UV-Stabilized Topical Formulation of Nifedipine for the Treatment of Raynaud Phenomenon and Chilblains
    Ellen K. Wasan et al
    Pharmaceutics 2019, 11(11), 594; https://doi.org/10.3390/pharmaceutics11110594
     
Loading...

Share This Page